New research shows that psilocybin treatment for major depression is effective for up to a year for most patients.
Read moreKetamine for Suicidal Thoughts
A new study shows that Ketamine effectively silences suicidal thoughts, especially in bipolar patients.
The effects wore off after 4-6 weeks however.
Read moreDMT and Depression
The first clinical trial using DMT for depression has promising results.
Read moreMore Research on Psychedelics
Here’s a look at the most recent, promising research on psychedelics and mental health.
Read morePsychedelics for Pain?
Some scientists believe that LSD and psilocybin could treat everything from cluster headaches to fibromyalgia.
Read moreLatest Research on Microdosing LSD
More on Psilocybin Therapy
5-MeO-DMT Research
This research reviews the available literature about 5-MeO-DMT and informs subsequent clinical development.
Read morePsilocybin-assisted Therapy
From Johns Hopkins Psychedelic Newsletter Fall 2021:
Last year, Dr. Frederick Barrett published a study that showed psilocybin reduced neural activity in the claustrum during the period of drug action.
The claustrum, once thought to be the seat of consciousness, is a thin sheet of gray matter in the brain that reaches out to every other region in the brain.
The results showed that both the default mode network and areas of the brain believed to be responsible for setting attention and switching tasks may be disrupted during the effects of psilocybin, and alterations in the claustrum may account for these changes.
Read moreMore Research Coming!
Well this is exciting: The DEA has proposed massively increasing the production of research-grade cannabis and psychedelics like LSD, psilocybin, and MDMA next year.
Read moreInterview with Rick Doblin
Keep reading for an interview with pioneering psychedelic activist Rick Doblin about the promise of MDMA therapy for PTSD, working with Republicans, and his hope for a drug-assisted global spiritual awakening.
Read more